Cogent Biosciences, Inc. (COGT)
NASDAQ: COGT · Real-Time Price · USD
33.54
+0.87 (2.66%)
May 26, 2026, 1:59 PM EDT - Market open
Cogent Biosciences Market Cap
Cogent Biosciences has a market cap or net worth of $5.73 billion as of May 26, 2026. Its market cap has increased by 910.33% in one year.
Market Cap
5.73B
Enterprise Value
5.10B
1-Year Change
910.33%
Ranking
Category
Stock Price
$33.54
Market Cap Chart
Since July 10, 2020, Cogent Biosciences's market cap has increased from $124.27M to $5.73B, an increase of 4,512.81%. That is a compound annual growth rate of 92.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 5.58B | 3.33% |
| Dec 31, 2025 | 5.40B | 527.16% |
| Dec 31, 2024 | 861.60M | 70.14% |
| Dec 29, 2023 | 506.41M | -37.32% |
| Dec 30, 2022 | 807.97M | 136.30% |
| Dec 31, 2021 | 341.92M | -2.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Centessa Pharmaceuticals | 6.15B |
| Apogee Therapeutics | 6.08B |
| Rhythm Pharmaceuticals | 6.02B |
| Mirum Pharmaceuticals | 6.01B |
| Scholar Rock Holding | 5.77B |
| PTC Therapeutics | 5.71B |
| CG Oncology | 5.67B |
| TG Therapeutics | 5.51B |